AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2020
Sep 8, 2020
30786_dirs_2020-09-08_35038189-b4f1-49fb-94fb-114a3af08a58.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-09-03
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-03 | Bio-Rad A Common Stock | M | 2319 | — | Acquired | 417501 | Direct |
| 2020-09-03 | Bio-Rad A Common Stock | F | 1150 | $494.24 | Disposed | 416351 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-03 | Restricted Stock Units | $0 | M | 2319 | Disposed | Bio-Rad A Common Stock (2319) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad B Common Stock | 12811 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad B Common Stock | 295122 | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: The reporting person disclaims beneficial ownership of these shares.
F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5: The restricted stock units vest in five equal annual installments beginning September 3, 2020.